Exclusive

Publication

Byline

BioMarin signs deal worth $475 M with Korea's GC Biopharma and Hanmi Pharm for potential treatment of Fabry Disease

Singapore, Oct. 30 -- US-based BioMarin Pharmaceutical Inc. has entered into an exclusive worldwide license agreement with South Korea-based GC Biopharma Corp. and Hanmi Pharm Co., to develop and comm... Read More


Japan's GHIT invests $6.8 M in product development for Malaria, NTDs and Ebola

Singapore, Oct. 30 -- Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.06 billion ($6.8 million) in nine R&D projects for the develop... Read More


Australia's Firebrick Pharma announces launch of Nasodine(R) Sinus Rinse in Singapore

Singapore, Oct. 30 -- Australia-based Firebrick Pharma has announced the launch of its third product in the Nasodine range: Nasodine(R) Sinus Rinse. The product recently completed production and comme... Read More


Waters launches AI-powered Peak Integration to strengthen software capabilities

Singapore, Oct. 30 -- Waters Corporation has announced AI-Powered Peak Integration, the next step in its strategy to build intelligent AI, machine learning, and automation cloud-based capabilities dir... Read More


DKSH to establish healthcare platform in Middle East and scale up capabilities with acquisition of NewBridge Pharma

Singapore, Oct. 30 -- DKSH has signed an agreement to acquire 100% of NewBridge Pharmaceuticals, a Dubai-headquartered healthcare commercialisation platform with operations across 14 markets in the ME... Read More


"The Future of Brain-Computer Interfaces Will Be Measured by Independence, Not Laboratory Performance"

Singapore, Oct. 29 -- Brain-computer interfaces (BCIs) are entering a new phase of technological development, moving beyond experimental demonstrations towards practical applications that could transf... Read More


PDRadiopharma injects JPY 16.5 B into new manufacturing facility in Japan

Singapore, Oct. 29 -- PeptiDream Inc., a public biopharmaceutical company based in Kawasaki, Japan, focused on the discovery and development of peptide- based therapeutics and PDRadiopharma Inc., a wh... Read More


Australia's Audax Biosciences inks immuno-oncology deal worth $1.34 B deal with Astellas Pharma

Singapore, Oct. 29 -- Japan-based Astellas Pharma Inc. has entered into an exclusive option and license agreement for DAX-044, Audax's lead immuno-oncology AVIKINE(R) candidate. Under the agreement, ... Read More


Jiahui launches International Cell Therapy Centre to expand global access to CAR-T treatment

Singapore, Oct. 29 -- Jiahui International Hospital has launched Jiahui International Cell Therapy Centre (JICC), building on landmark CAR-T cases and multidisciplinary expertise to serve patients fro... Read More


Singapore approves Merck's CAPVAXIVE 21-valent pneumococcal conjugate vaccine

Singapore, Oct. 29 -- American multinational pharmaceutical company Merck (Known as Merck Sharp & Dohme or MSD outside the United States and Canada) has announced that the Health Sciences Authority (H... Read More